Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Will Reach USD 16,487.4 Million by 2026: Facts & Factors New York, NY, May 07, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “B-Cell Maturation Antigen (BCMA) Targeted Therapies Market by Product Type (CAR-T cell,...

Significant Number of B-cell Maturation Antigen (BCMA) Targeted Therapies in Pipeline is Expected to Boost Market Growth SEATTLE, Oct. 26, 2017 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market (By product type: CAR-T cell, bispecific...